75° Sunny

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioNTech SE - American Depositary Shares (NQ:BNTX)

88.73 -0.81 (-0.91%)

Streaming Delayed Price Updated: 10:02 AM EDT, May 18, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioNTech SE - American Depositary Shares

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

72 73 Next >

Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank Fears: Weekly Review ↗

March 31, 2023

The stock market rallied on ebbing bank fears and positive news from Micron, Alibaba and Lululemon Athletica.

Via Investor's Business Daily

Bear of the Day: BioNTech ↗

March 28, 2023

BioNTech was relatively obscure until the company partnered with pharmaceutical juggernaut Pfizer (PFE) to develop one of the first mRNA COVID-19 vaccines.

Via Talk Markets

These Analysts Revise Price Targets On BioNTech After Q4 Results ↗

March 28, 2023

BioNTech SE (NASDAQ: BNTX) reported a decline in sales for its fourth quarter.

Via Benzinga

NVIDIA To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

March 28, 2023

B of A Securities cut the price target for Fox Corporation (NASDAQ: FOXA) from $42 to $34. B of A Securities analyst Jessica Reif Ehrlich downgraded the stock from Buy to Neutral. Fox shares fell 1.8%...

Via Benzinga

Why Shares of BioNTech Slumped Monday ↗

March 27, 2023

The company released fourth-quarter earnings.

Via The Motley Fool

BioNTech Earnings Preview ↗

March 24, 2023

Via Benzinga

4 Analysts Have This to Say About BioNTech ↗

March 23, 2023

Via Benzinga

Price Over Earnings Overview: BioNTech ↗

March 20, 2023

Via Benzinga

BioNTech Announces New ADS Repurchase Program

March 28, 2023

From BioNTech SE

Via GlobeNewswire

Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗

March 27, 2023

Benzinga

Via Benzinga

BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday ↗

March 27, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

BioNTech Q4 2022 Earnings Conference Call On March 27, 2023 At 08:00 AM ET ↗

March 16, 2023

Via Benzinga

BioNTech Is Ripe For A Rebound In 2023

March 27, 2023

BioNTech had a strong quarter and may become a takeover target due to its healthy pipeline and a looming patent cliff for big pharma.

Via MarketBeat

Topics Intellectual Property

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion ↗

March 27, 2023

For the year, BioNTech said it expects about $5.4 billion in sales of its Covid shot.

Via Investor's Business Daily

Why BioNTech Shares Are Trading Lower Today ↗

March 27, 2023

BioNTech SE (NASDAQ: BNTX) shares are falling in the premarket session today after the company reported Q4 earnings and expected lower annual revenue from the Covid-19 vaccine.

Via Benzinga

Earnings Scheduled For March 27, 2023 ↗

March 27, 2023

Companies Reporting Before The Bell • Viomi Technology Co (NASDAQ:VIOT) is likely to report earnings for its fourth quarter. • Vislink Technologies (NASDAQ:VISL) is projected to report earnings for its...

Via Benzinga

US Stocks Poised To Start New Trading Week Higher On Hopes Of Resolving Banking Crisis: Analyst Warns 'No News Would Be Good News' ↗

March 27, 2023

The recent positive momentum seen in the market could carry over into the new week, as indicated by the index futures, which were holding up early Monday.

Via Benzinga

BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

March 27, 2023

From BioNTech SE

Via GlobeNewswire

Could CRISPR Therapeutics Become the Next Moderna? ↗

March 27, 2023

Both companies use cutting-edge technology.

Via The Motley Fool

Carnival, BioNTech And 3 Stocks To Watch Heading Into Monday ↗

March 27, 2023

With US futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Fear Increases Amid Recent Bank Concerns ↗

March 27, 2023

The CNN Money Fear and Greed index showed some increase in the fear level among U.S. investors. US stocks closed higher on Friday following a volatile trading session. All the major indices recorded...

Via Benzinga

7 Blue-Chip Stocks Sitting in the Sweet Spot ↗

March 23, 2023

Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.

Via InvestorPlace

China's First mRNA Vaccine: Drugmaker CSPC Wins China's Approval For COVID-19 Vaccine ↗

March 22, 2023

Chinese health authorities approved CSPC Pharmaceuticals Group Ltd's (OTC: CSPCY) messenger RNA (mRNA) COVID-19 vaccine for emergency use authorization.

Via Benzinga

Additional COVID-19 Booster Shots? Officials Anticipate FDA Authorization Within Few Weeks ↗

March 21, 2023

The U.S. Food and Drug Administration is reportedly moving toward authorizing a second round of omicron-targeted COVID-19 booster shots for the elderly and other people at high risk.

Via Benzinga

Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders ↗

March 21, 2023

Moderna CEO Stephane Bancel will face a Senate Committee over pricing plans.

Via Investor's Business Daily

Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information ↗

March 21, 2023

Via Benzinga

Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose ↗

March 21, 2023

From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector.

Via Benzinga

BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

March 20, 2023

From BioNTech SE

Via GlobeNewswire

7 Stocks Set to Soar When the Market Recovers ↗

March 16, 2023

Daring contrarians can bid up the danger with these intriguing market ideas.

Via InvestorPlace

FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids ↗

March 15, 2023

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

BioNTech SE - American Depositary Shares (NQ:BNTX)

All News about BioNTech SE - American Depositary Shares

Sections

Services